Recognition awarded for sustainable clinical excellence in quality performance outcomes for patients
Medical City Dallas announced today that it has earned recognition as a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the United States.
Medical City Dallas was recognized for attaining and sustaining excellence in accountability measure performance for heart attack, heart failure, pneumonia, surgical care, children’s asthma, and perinatal care, and is one of 1,043 hospitals out of more than 3,300 eligible hospitals in the United States to achieve the 2014 Top Performer distinction.
“This prestigious recognition from The Joint Commission is a direct reflection of Medical City’s dedication to evidence-based clinical practices that help ensure the best possible outcomes for the patients we’re privileged to treat,” said Troy Villarreal, FACHE, Chief Executive Officer at Medical City Dallas. “We are proud to be named a Top Performer as it recognizes the knowledge, teamwork and dedication of our entire hospital staff to our mission for the care and improvement of human life.”
The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions, including heart attack, heart failure, pneumonia, surgical care, children’s asthma, stroke, venous thromboembolism and perinatal care, as well as for inpatient psychiatric services and immunizations.
This is the third year that Medical City Dallas has been recognized as a Top Performer. Medical City Dallas was recognized in 2012 for heart failure, heart attack, pneumonia and surgical care; and in 2011 for heart failure, heart attack, pneumonia and children’s asthma. For more information about The Joint Commission’s Top Performer on Key Quality Measures® program, visit http://www.jointcommission.org/accreditation/top_performers.aspx.